# Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence

> **NCT00142818** · PHASE2 · COMPLETED · sponsor: **Kyle Kampman** · enrollment: 164 (actual)

## Conditions studied

- Alcohol-Related Disorders
- Alcoholism
- Cocaine-Related Disorders

## Interventions

- **DRUG:** Naltrexone
- **DRUG:** Modafinil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00142818
- **Lead sponsor:** Kyle Kampman
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2020-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00142818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00142818, "Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00142818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*